Skip to main content
Hugel, Inc. logo

Hugel, Inc. — Investor Relations & Filings

Ticker · 145020 ISIN · KR7145020004 KO Manufacturing
Open in API
Filings indexed 499 across all filing types
Latest filing 2024-07-31 Report Publication Anno…
Country KR South Korea
Listing KO 145020

About Hugel, Inc.

https://www.hugel-inc.com/

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.

Recent filings

Filing Released Lang Actions
결산실적공시예고
Report Publication Announcement Classification · 100% confidence The document is a short announcement titled '결산실적공시 예고' (Notice of Earnings Release Schedule) from Hugel, Inc. It informs investors of the upcoming date (2024-08-07) for the release of their 2024 Q2 financial results. Since it is a brief notification regarding the timing of a future report rather than the financial report itself, it falls under the Report Publication Announcement (RPA) category.
2024-07-31 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (884 characters) notifying the public of an upcoming Investor Relations (IR) event (a conference call) to discuss 2024 Q2 financial results. It provides the date, time, and location of the event, and mentions that materials will be posted on the company website. Per the 'Menu vs Meal' rule, since this is an announcement of an event/report rather than the report itself, and it serves as a regulatory notification of an IR activity, it is classified as a Report Publication Announcement (RPA).
2024-07-31 Korean
신탁계약에의한취득상황보고서
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Acquisition Status via Trust Agreement' (신탁계약등에의한취득상황보고서) filed by Hugel Inc. with the Financial Supervisory Service (FSS). It details the company's share buyback activities conducted through a trust agreement with NH Investment & Securities. This type of filing is a standard regulatory disclosure in South Korea regarding a company's transaction in its own shares (share repurchase). Therefore, it falls under the 'Transaction in Own Shares' category.
2024-06-28 Korean
기타시장안내 (업종변경 안내)
Regulatory Filings Classification · 100% confidence The document is a short announcement from Hugel regarding a change in its industry classification code due to an update in the Korean Standard Industrial Classification. It is a regulatory notification provided to the Korea Exchange (KRX) and does not fit into specific financial reporting categories like 10-K, IR, or ER. As it is a general regulatory announcement that does not fall into the other specific categories, it is classified as a Regulatory Filing (RNS).
2024-06-28 Korean
투자판단관련주요경영사항 (미국 국제무역위원회ITC, International Trade Commission 예비심결 결과 확인)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Hugel regarding a legal proceeding (ITC investigation). It details the 'Initial Determination' of a lawsuit involving Medytox and Hugel. Since it reports on the status of a significant legal matter/regulatory action, it falls under the 'Legal Proceedings Report' category.
2024-06-11 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Hugel regarding the exercise of conversion rights (convertible bonds). It details the number of shares to be issued, the conversion price, and the updated listing date. This type of corporate action, involving the conversion of debt into equity, falls under capital structure changes and share issuance, which is best classified as 'Share Issue/Capital Change' (SHA).
2024-06-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.